Orthopedic Navigation System Market Scope And Analysis

  • Report Code : TIPRE00020497
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 152
Buy Now

Orthopedic Navigation Systems Market Analysis and Scope (2023 to 2030)

Buy Now


Orthopedic Navigation Systems Market Report Scope

Report Attribute Details
Market size in 2022 US$ 2.53 Billion
Market Size by 2030 US$ 7.48 Billion
Global CAGR (2022 - 2030) 14.5%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Technology
  • Electromagnetic
  • Optical
By Application
  • Knee
  • Hip
  • Spine
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Smith Nephew
  • Siemens Healthineers
  • Brainlab AG
  • Metronor
  • Naviswiss AG
  • B Braun SE
  • Stryker Corporation
  • Medtronic PLC
  • Zimmer Biomet
  • The report profiles leading players operating in the global orthopedic navigation systems market. B. Braun SE, Stryker Corporation, Medtronic PLC, Zimmer Biomet, DePuy Synthes, Smith & Nephew, Siemens Healthineers, Brainlab AG, Metronor, and Naviswiss AG are a few market players.

    • In June 2023, Brainlab AG collaborated with AO Foundation to extend reality technology for best practices in education and training. This collaboration will increase knowledge acquisition, enhance decision making, and improve coordination of skills, all within a safe and engaging setting.
    • In May 2023, DePuy Synthes demonstrated Reality Based Navigation (RBN), a new addition to their hip offering throughout Europe and the Middle East & Africa. Professor David Beverland MD, FRCS Consultant Orthopedic Surgeon, pioneered the concept in Belfast, Northern Ireland, during the last three decades, beginning with a fellowship with Mike Wroblewski in 1988 and growing into a collaborative endeavor supported by over 40 fellows. The goal of RBN is for surgeons to be able to obtain more reproducible results with a simple, low-cost approach, guaranteeing that every patient has access to the same high-level standard of care. RBN was created to limit the number of outliers in component positioning1, potentially increasing accuracy during THA. As one of the key goals underlying the notion of RBN is to reduce or eliminate outliers, the implementation of RBN is designed to assist surgeons in reducing any such outliers in their practices.
    • In February 2023, Naviswiss received clearance from the FDA to market Naviswiss Knee in the US. The Naviswiss Knee solution is a landmark-based navigation tool that helps the surgeon insert and align the knee replacement implants in the best possible way. An orthopedic surgeon can use Naviswiss Knee to select between an express workflow that just navigates Varus/Valgus alignment and Flexion/Extension, or an advanced workflow that also navigates Medial and Lateral resection height and Range of Motion overviews.
    • In November 2022, Corin Australia Pty Ltd and Naviswiss AG signed an exclusive distribution agreement for Australia and New Zealand. Corin Australia Pty Ltd is a major inventor in miniaturized navigation for joint replacement surgery. The addition of this technology will strengthen the OPS offering and value to customers.